[1] |
JIA Zhenzhen, HE Shuang, LI Yangyang, WEN Feifei, XU Xiaoyang, GUO Ningjie, WU Shuhua.
Correlations between expressions of DPD, LC3 and P62 in colorectal cancer and their clinical significance
[J]. China Oncology, 2022, 32(1): 24-33.
|
[2] |
ZHOU Mingliang, SONG Zhangfa, LI Zhenjun.
A case of rectal stromal tumor resection by da Vinci robotic surgery without an assisted abdominal incision
[J]. China Oncology, 2022, 32(1): 75-79.
|
[3] |
LU Renquan, LIU Guangyu, YANG Wentao, GUO Lin, GUAN Ming, SHAO Zhimin, XU Dazhi, NI Ming, TANG Feng, WANG Chaofu, LOU Jiatao, SUN Fenyong, XING Jinliang, PAN Yueyin.
Application consensus of peripheral blood HER2 gene amplification detection (digital PCR) in anti-HER2 therapy
[J]. China Oncology, 2022, 32(1): 90-96.
|
[4] |
ZHANG Xiaoyan , LI Qingxiang , LIU Yong , LI Hang , QIU Lijuan , FENG Xinran , TAN Liming .
A study on the correlation between HMGB1 and clinical characteristics and immune function in patients with breast cancer
[J]. China Oncology, 2021, 31(9): 783-788.
|
[5] |
YAO Jia , LI Guanqiao , YANG Shiping , SU Huiluan .
Effect of hsa-miR-98-5p/DKK3 signal axis on biological behavior of breast cancer cells
[J]. China Oncology, 2021, 31(9): 807-816.
|
[6] |
PENG Hui , ZHANG Zhifa , ZHU Xianqiang , ZHANG Xiaohan , QIN Haili .
A study of correlation between poorly differentiated clusters and clinicopathological parameters in colorectal adenocarcinoma
[J]. China Oncology, 2021, 31(9): 817-821.
|
[7] |
HE Xiaoshun , JIAO Weijuan , GUO Lingchuan , HUANG Shan , WU Yujin , HUANG Renpeng .
A clinicopathological analysis of 6 cases with dysembryoplastic neuroepithelial tumor
[J]. China Oncology, 2021, 31(9): 822-827.
|
[8] |
YANG Yanju, ZHONG Yang, HU Weigang, GAO Dadi, ZHAO Jun.
Effects of CT-RED calibration curves of different simulators on dose distribution of tumor target and organs at risk
[J]. China Oncology, 2021, 31(9): 828-837.
|
[9] |
LU Li, LU Renquan, SUN Jiajun, LU Ning, GUO Lin.
The application of serum N-MID in auxiliary diagnosis and therapeutic effect monitoring of bone metastasis in patients with primary lung cancer
[J]. China Oncology, 2021, 31(9): 838-844.
|
[10] |
MA Yifei , LIANG Xinjun , WEI Shaozhong .
Prognostic value of inflammatory and immune markers in resectable colorectal cancer
[J]. China Oncology, 2021, 31(9): 845-851.
|
[11] |
Tumor Support and Rehabilitation Therapy Group, the Oncology Committee of Chinese Medical Association.
Clinical practice guidelines for cancer-related fatigue in China (2021 edition)
[J]. China Oncology, 2021, 31(9): 852-872.
|
[12] |
LEI Yajie , GAO Yi , WANG Zhijie , CHENG Xi , YANG Yufei , ZHOU Hongyu , CHEN Lihua , CHEN Yixin , LI Haoran , LI Ziting , WU Xiaohua .
Potential role of lymphadenectomy in patients with ovarian cancer (ⅠC-ⅡA): a retrospective trial
[J]. China Oncology, 2021, 31(8): 740-745.
|
[13] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[14] |
ZHANG Yingqiang , LIN Yansong .
Application and research progress of 90 Y microspheres internal radiation therapy in colorectal cancer with liver metastasis
[J]. China Oncology, 2021, 31(8): 762-768.
|
[15] |
LI Haizhou , ZHANG Yanwei , XU Yingjie , YANG Men , ZHANG Lei , HAN Jingjun .
miR-933 inhibits proliferation, migration and invasion of lung cancer cell lines by regulation of KLF6 gene
[J]. China Oncology, 2021, 31(7): 581-588.
|